One Liquid Biopsy Screening for Cancers

A single blood test that screens for eight common cancer types and helps identify the location of the cancer has been developed at the Johns Hopkins Kimmel Cancer Center. The test, called CancerSEEK, is a unique noninvasive, multianalyte test that simultaneously evaluates levels of eight cancer proteins and the presence of cancer gene mutations from circulating DNA in the blood. The test is aimed at screening for eight common cancer types that account for more than 60 percent of cancer deaths in the U.S. Five of the cancers covered by the test currently have no screening test.